Publication | Open Access
Cholecalciferol in relapsing-remitting MS: A randomized clinical trial (CHOLINE)
95
Citations
13
References
2019
Year
This study provides Class II evidence that for patients with RRMS and low serum 25OHD, cholecalciferol did not significantly affect ARRs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1